LNAI
Lunai Bioworks Inc.
Company overview
- Market capitalization
- $67.46M
- Employees
- 29
- Latest publication
- 2026-09-29
About Lunai Bioworks Inc.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
Financial statements
Income Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20,942USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 11,000USD | 11,332USD | 41,522USD | 32,626USD | 0USD | — | — | — |
| Gross Profit | 9,941USD | -11,332USD | -41,522USD | -32,626USD | 0USD | — | — | — |
| Research Development | 15,945USD | 45,872USD | 24,407USD | 80,228USD | 94,073USD | 161,084USD | 390,189USD | 434,508USD |
| Selling General Administrative | 1,421,255USD | 1,766,210USD | 2,410,516USD | 4,001,087USD | 4,224,590USD | 4,353,123USD | 5,301,251USD | 4,998,627USD |
| Total Operating Expenses | 1,437,201USD | 1,812,082USD | 2,434,923USD | 4,081,315USD | 4,162,492USD | 4,546,316USD | 53,338,554USD | 51,294,267USD |
| Operating Income | -1,427,260USD | -1,823,414USD | -2,476,445USD | -4,113,940USD | -4,162,492USD | -4,546,316USD | -53,338,554USD | -51,294,267USD |
| Interest Expense | 108,052USD | 121,508USD | 188,685USD | 188,028USD | 188,685USD | 116,078USD | 250,080USD | 1,676,714USD |
| Net Interest Income | -128,018USD | -115,990USD | -89,103USD | -181,165USD | -188,613USD | -116,078USD | -123,482USD | -1,684,755USD |
| Income Before Tax | -2,571,394USD | -1,799,404USD | 2,819,021USD | -126,732,236USD | 189,176USD | -7,252,394USD | -44,212,036USD | -49,921,609USD |
| Net Income | -2,571,394USD | -1,799,404USD | 2,819,021USD | -126,732,236USD | 189,176USD | -7,252,394USD | -44,212,036USD | -49,921,609USD |
| Net Income From Continuing Ops | -2,571,394USD | -1,799,404USD | 2,819,021USD | -126,732,236USD | 189,176USD | -7,252,394USD | -44,212,036USD | -49,921,609USD |
| Ebit | -1,427,259USD | -1,823,414USD | -2,476,445USD | -4,113,940USD | 377,861USD | -7,136,316USD | -43,961,956USD | -48,244,895USD |
| Ebitda | -1,416,259USD | -1,812,082USD | -2,434,923USD | -4,081,314USD | 409,836USD | -7,104,207USD | -43,929,571USD | -48,213,763USD |
| Depreciation And Amortization | 11,000USD | 11,332USD | 41,522USD | 32,626USD | 31,975USD | 32,109USD | 32,385USD | 31,132USD |
| Reconciled Depreciation | 19,634USD | 11,183USD | 41,522USD | 32,626USD | 31,975USD | 32,109USD | 32,385USD | 31,132USD |
| Total Other Income Expense Net | -1,144,134USD | 24,010USD | 5,295,466USD | -122,618,296USD | 4,351,668USD | -2,706,078USD | 9,126,518USD | 1,372,658USD |
| Interest Income | — | 5,518USD | 33,297USD | 6,863USD | 72USD | — | 126,598USD | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | 47,647,114USD | 45,861,132USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 129,094USD | — | — | — | 391,416USD |
| Gross Profit | -129,094USD | 0USD | 0USD | — | -391,416USD |
| Research Development | 537,428USD | 2,708,829USD | 4,165,197USD | 8,372,800USD | 15,538,122USD |
| Selling General Administrative | 17,880,050USD | 24,557,608USD | 15,318,198USD | 14,329,801USD | — |
| Total Operating Expenses | 18,417,478USD | 81,639,296USD | 38,556,891USD | 116,079,191USD | 23,010,371USD |
| Operating Income | -18,546,573USD | -81,639,296USD | -38,556,891USD | -116,079,191USD | -23,401,787USD |
| Interest Income | 116,346USD | — | — | 122,041USD | — |
| Interest Expense | 725,684USD | 2,434,771USD | 706,964USD | 372,844USD | 379,608USD |
| Net Interest Income | -609,338USD | -2,434,771USD | -706,964USD | -250,803USD | — |
| Income Before Tax | -178,007,489USD | -88,425,828USD | -39,684,056USD | -113,433,358USD | -26,848,883USD |
| Net Income | -178,007,489USD | -88,425,828USD | -39,684,056USD | -113,433,392USD | -26,723,607USD |
| Net Income From Continuing Ops | -178,007,489USD | -88,425,828USD | -39,684,056USD | -113,433,392USD | — |
| Ebit | -18,546,574USD | -85,991,057USD | -38,977,092USD | -113,060,514USD | -26,469,271USD |
| Ebitda | -18,417,479USD | -85,869,198USD | -38,863,596USD | -112,936,924USD | -26,077,855USD |
| Depreciation And Amortization | 129,095USD | 121,859USD | 113,496USD | 123,590USD | 391,416USD |
| Reconciled Depreciation | 129,095USD | 121,859USD | 113,496USD | 123,590USD | — |
| Total Other Income Expense Net | -159,460,916USD | -6,786,532USD | -1,127,165USD | 2,645,833USD | -3,447,096USD |
| Unclassified Operating Expenses | — | 54,372,859USD | 19,073,496USD | 93,376,590USD | 7,472,249USD |
| Tax Provision | — | — | 0USD | 34USD | — |
| Income Tax Expense | — | — | — | 34USD | -125,276USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,860,540USD | 6,666,446USD | 6,960,663USD | 8,230,840USD | 117,726,120USD | 111,340,272USD | 121,832,637USD | 163,129,450USD |
| Intangible Assets | 119,114USD | 142,096USD | 152,980USD | 165,994USD | 16,172USD | 17,853USD | 28,750USD | 30,043USD |
| Other Current Assets | 577,378USD | 22,844USD | 175,552USD | 566,081USD | 943,302USD | 1,269,417USD | 485,228USD | 668,929USD |
| Total Liab | 19,413,968USD | 20,215,234USD | 20,001,437USD | 29,580,681USD | 29,339,269USD | 29,280,954USD | 23,745,639USD | 31,152,306USD |
| Total Stockholder Equity | -9,553,428USD | -13,548,788USD | -13,040,774USD | -21,349,841USD | 88,386,851USD | 82,059,318USD | 98,086,998USD | 131,977,144USD |
| Other Current Liab | 5,327,382USD | 5,121,819USD | 5,200,115USD | 6,851,351USD | 10,582,002USD | 11,979,912USD | 8,522,195USD | 17,916,685USD |
| Common Stock | 3,577USD | 2,419USD | 2,318USD | 17,741USD | 16,241USD | 16,216USD | 15,763USD | 15,847USD |
| Capital Stock | 3,577USD | 2,419USD | 2,318USD | 17,741USD | 16,241USD | 16,216USD | 15,763USD | 15,847USD |
| Retained Earnings | -512,014,347USD | -509,442,953USD | -507,643,549USD | -510,462,570USD | -383,730,334USD | -383,919,510USD | -368,891,461USD | -332,455,081USD |
| Good Will | 5,963,000USD | 5,963,000USD | 5,963,000USD | 5,963,000USD | 112,642,272USD | 107,999,273USD | 118,171,345USD | 159,330,161USD |
| Cash | 3,155,272USD | 491,645USD | 624,808USD | 92,700USD | 923,000USD | 311,764USD | 220,571USD | 220,467USD |
| Cash And Short Term Investments | 3,155,272USD | 491,645USD | 624,808USD | 480,551USD | 1,633,283USD | 311,764USD | 220,571USD | 220,467USD |
| Total Current Assets | 3,732,650USD | 514,489USD | 800,360USD | 1,046,632USD | 3,668,054USD | 1,708,261USD | 1,948,159USD | 1,997,643USD |
| Total Current Liabilities | 19,282,652USD | 20,001,577USD | 19,722,474USD | 29,156,134USD | 28,841,640USD | 28,606,754USD | 23,035,379USD | 30,309,917USD |
| Net Debt | -1,743,905USD | 2,475,808USD | 2,082,086USD | 10,080,791USD | 6,108,207USD | 6,054,723USD | 3,600,650USD | 3,566,471USD |
| Short Term Debt | 1,280,051USD | 2,540,139USD | 2,427,931USD | 9,748,944USD | 6,533,580USD | 5,692,287USD | 3,110,961USD | 2,944,549USD |
| Short Long Term Debt | 991,661USD | 2,265,156USD | 2,150,156USD | 9,435,897USD | 5,985,897USD | 5,130,000USD | 2,606,707USD | 2,450,996USD |
| Short Long Term Debt Total | 1,411,367USD | 2,967,453USD | 2,706,894USD | 10,173,491USD | 7,031,209USD | 6,366,487USD | 3,821,221USD | 3,786,938USD |
| Short Term Investments | 0USD | 0USD | 0USD | 387,851USD | 710,281USD | — | — | 0USD |
| Accounts Payable | 12,675,219USD | 12,339,619USD | 12,094,428USD | 12,555,839USD | 11,726,058USD | 10,934,555USD | 11,402,223USD | 9,448,683USD |
| Property Plant Equipment Net | 12,956USD | 13,253USD | 12,465USD | 1,055,214USD | 1,385,476USD | 1,602,831USD | 1,602,686USD | 1,751,754USD |
| Property Plant Equipment Gross | 12,956USD | 13,253USD | 12,465USD | 1,757,394USD | 1,385,476USD | 1,602,831USD | 1,602,686USD | 2,330,094USD |
| Accumulated Other Comprehensive Income | -155,698USD | -139,023USD | -128,161USD | 10,814,842USD | 775,611USD | -3,847,603USD | 6,297,215USD | -170,846USD |
| Common Stock Shares Outstanding | 3,124,275shares | 2,935,339shares | 2,815,031shares | 2,082,512shares | 2,049,131shares | 2,022,815shares | 1,999,917shares | 1,609,406shares |
| Non Current Assets Total | 6,127,890USD | 6,151,956USD | 6,160,303USD | 7,184,208USD | 114,058,066USD | 109,632,011USD | 119,884,478USD | 161,131,807USD |
| Non Current Liabilities Total | 131,316USD | 213,656USD | 278,963USD | 424,547USD | 497,629USD | 674,200USD | 710,260USD | 842,389USD |
| Non Currrent Assets Other | 32,819USD | 33,607USD | 31,858USD | — | 14,146USD | 12,054USD | 81,697USD | 19,849USD |
| Net Working Capital | -15,550,002USD | -19,487,088USD | -18,922,114USD | -28,109,502USD | -25,173,586USD | -26,898,493USD | -21,087,220USD | -28,312,274USD |
| Unclassified Equity | 502,609,463USD | 496,028,350USD | 494,726,300USD | 478,262,405USD | 471,309,092USD | 469,793,999USD | 460,649,718USD | 464,571,377USD |
| Unclassified Current Liabilities | — | -2,265,156USD | -2,150,156USD | -9,435,897USD | -5,985,897USD | -5,130,000USD | -2,606,707USD | -2,450,996USD |
| Net Receivables | — | — | — | — | 1,091,469USD | 127,080USD | 1,242,360USD | 1,108,247USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|
| Total Assets | 8,230,840USD | 163,129,450USD | 58,300,796USD | 84,632,663USD | 189,605,225USD |
| Intangible Assets | 165,994USD | 30,043USD | 42,650,676USD | 61,615,268USD | 154,889,906USD |
| Other Current Assets | 566,081USD | 668,929USD | 690,925USD | 392,996USD | 232,943USD |
| Total Liab | 29,580,681USD | 31,152,306USD | 11,798,685USD | 12,013,815USD | 14,942,286USD |
| Total Stockholder Equity | -21,349,841USD | 131,977,144USD | 46,502,111USD | 72,618,848USD | 174,662,939USD |
| Other Current Liab | 6,851,351USD | 17,916,685USD | 907,906USD | 3,595,465USD | 1,212,327USD |
| Common Stock | 17,741USD | 15,847USD | 6,371USD | 5,302USD | 5,222USD |
| Capital Stock | 17,741USD | 15,847USD | 6,371USD | 5,302USD | — |
| Retained Earnings | -510,462,570USD | -332,455,081USD | -244,029,253USD | -204,345,197USD | -90,911,805USD |
| Good Will | 5,963,000USD | 159,330,161USD | 11,640,000USD | 11,640,000USD | 11,640,000USD |
| Cash | 92,700USD | 220,467USD | 1,874,480USD | 9,172,142USD | 20,664,410USD |
| Cash And Short Term Investments | 480,551USD | 220,467USD | 1,874,480USD | 9,172,142USD | 20,664,410USD |
| Total Current Assets | 1,046,632USD | 1,997,643USD | 2,565,405USD | 9,565,138USD | 20,898,993USD |
| Total Current Liabilities | 29,156,134USD | 30,309,917USD | 11,023,098USD | 6,450,968USD | 1,885,893USD |
| Net Debt | 10,080,791USD | 3,566,471USD | 3,719,476USD | -2,155,659USD | -13,292,955USD |
| Short Term Debt | 9,748,944USD | 2,944,549USD | 4,818,369USD | 1,453,636USD | 353,007USD |
| Short Long Term Debt | 9,435,897USD | 2,450,996USD | 4,624,947USD | 1,200,000USD | — |
| Short Long Term Debt Total | 10,173,491USD | 3,786,938USD | 5,593,956USD | 7,016,483USD | 7,371,455USD |
| Short Term Investments | 387,851USD | 0USD | — | — | — |
| Accounts Payable | 12,555,839USD | 9,448,683USD | 5,296,823USD | 1,401,867USD | 320,559USD |
| Property Plant Equipment Net | 1,055,214USD | 1,751,754USD | 1,422,974USD | 1,743,622USD | 2,155,342USD |
| Property Plant Equipment Gross | 1,757,394USD | 2,330,094USD | 1,887,773USD | 2,101,100USD | — |
| Accumulated Other Comprehensive Income | 10,814,842USD | -170,846USD | -29,882USD | -30,436USD | -10,834USD |
| Common Stock Shares Outstanding | 2,063,275shares | 1,218,894shares | 703,317shares | 656,600shares | 589,591shares |
| Non Current Assets Total | 7,184,208USD | 161,131,807USD | 55,735,391USD | 75,067,525USD | 168,706,232USD |
| Non Current Liabilities Total | 424,547USD | 842,389USD | 775,587USD | 5,562,847USD | 13,056,393USD |
| Net Working Capital | -28,109,502USD | -28,312,274USD | -8,457,693USD | 3,114,170USD | — |
| Unclassified Current Liabilities | -9,435,897USD | -2,450,996USD | -4,624,947USD | -1,200,000USD | — |
| Unclassified Equity | 478,262,405USD | 464,571,377USD | 290,548,504USD | 276,983,877USD | 265,580,356USD |
| Net Receivables | — | 1,108,247USD | — | — | 1,640USD |
| Non Currrent Assets Other | — | 19,849USD | 21,741USD | 68,635USD | 20,984USD |
| Long Term Debt | — | — | — | 4,577,148USD | — |
| Unclassified Non Current Liabilities | — | — | — | — | 13,056,393USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,571,394USD | -1,799,404USD | 2,819,021USD | -126,732,236USD | 189,176USD | -7,252,393USD | -44,212,036USD | -49,921,609USD |
| Depreciation | 11,000USD | 11,332USD | 41,522USD | 32,626USD | 31,975USD | 32,109USD | 32,385USD | 31,132USD |
| Stock Based Compensation | 168,993USD | 128,819USD | 181,312USD | 897,813USD | 1,499,199USD | 558,631USD | 357,648USD | 828,471USD |
| Other Non Cash Items | 1,215,241USD | 297,350USD | -5,388,397USD | 122,437,131USD | -4,524,338USD | 3,129,205USD | 39,788,449USD | 42,952,573USD |
| Change To Account Receivables | -62,079USD | -1,750USD | -6,407USD | 166,898USD | -2,092USD | 1,184,923USD | -195,961USD | -1,108,247USD |
| Change In Working Capital | 318,296USD | 419,509USD | 997,432USD | 1,553,530USD | 1,316,529USD | 972,724USD | 2,017,226USD | 3,695,652USD |
| Total Cash From Operating Activities | -1,026,856USD | -1,071,213USD | -1,349,110USD | -1,811,136USD | -1,487,459USD | -2,559,724USD | -2,016,328USD | -2,413,781USD |
| Capital Expenditures | -4USD | -1,237USD | 0USD | 0USD | 0USD | 0USD | 0USD | -23,552USD |
| Free Cash Flow | -1,026,860USD | -1,072,450USD | -1,349,110USD | -1,811,136USD | -1,487,459USD | -2,559,724USD | -2,016,328USD | -2,437,333USD |
| Investments | 0USD | 0USD | 544,700USD | 964,389USD | -1,464,389USD | 0USD | 0USD | -53,373USD |
| Net Borrowings | -492,001USD | 200,000USD | 1,615,000USD | 3,450,000USD | 855,896USD | 2,514,979USD | 156,947USD | — |
| Total Cash From Financing Activities | 3,703,512USD | 950,000USD | 1,343,357USD | 178,357USD | 3,584,253USD | 2,590,979USD | 2,029,183USD | 2,466,718USD |
| Issuance Of Capital Stock | 4,499,551USD | 750,000USD | 0USD | 0USD | 0USD | 280,000USD | 2,096,181USD | 0USD |
| Change In Cash | 2,663,627USD | -133,163USD | 532,108USD | -830,302USD | 611,238USD | 91,193USD | 104USD | -92,230USD |
| Begin Period Cash Flow | 491,645USD | 624,808USD | 92,700USD | 923,000USD | 311,764USD | 220,571USD | 220,467USD | 312,697USD |
| End Period Cash Flow | 3,155,272USD | 491,645USD | 624,808USD | 92,700USD | 923,000USD | 311,764USD | 220,571USD | 220,467USD |
| Total Cashflows From Investing Activities | — | -1,238USD | 544,700USD | 964,389USD | -1,464,389USD | — | — | -53,373USD |
| Other Cashflows From Financing Activities | — | — | -271,643USD | -3,271,643USD | 2,728,357USD | -204,000USD | -223,945USD | -223,945USD |
| Other Cashflows From Investing Activities | — | — | — | — | -1,464,389USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | 1,464,389USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | 2,690,663USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|
| Net Income | -178,007,489USD | -88,425,828USD | -39,684,056USD | -113,433,392USD | -26,723,607USD |
| Depreciation | 129,095USD | 121,859USD | 113,496USD | 123,590USD | 391,416USD |
| Stock Based Compensation | 3,313,291USD | 4,673,129USD | 3,535,051USD | 5,490,602USD | — |
| Other Non Cash Items | 160,830,447USD | 63,847,556USD | 19,955,803USD | 90,671,753USD | 4,789,335USD |
| Change To Account Receivables | 1,153,768USD | -1,108,247USD | 46USD | 1,594USD | 342USD |
| Change In Working Capital | 5,860,009USD | 8,811,854USD | 4,305,157USD | 1,415,111USD | 932,133USD |
| Total Cash From Operating Activities | -7,874,647USD | -10,971,430USD | -11,774,549USD | -15,732,336USD | -20,610,723USD |
| Capital Expenditures | -3USD | -70,430USD | -29,774USD | -5,156USD | -48,887USD |
| Free Cash Flow | -7,874,647USD | -11,041,860USD | -11,804,323USD | -15,737,492USD | -20,659,610USD |
| Investments | -500,000USD | -1,260,179USD | -29,774USD | -5,156USD | — |
| Total Cashflows From Investing Activities | -500,000USD | -1,260,179USD | -29,774USD | -5,156USD | -48,892USD |
| Net Borrowings | 6,977,822USD | 8,045,663USD | 0USD | -560,848USD | — |
| Total Cash From Financing Activities | 8,382,772USD | 10,517,455USD | 4,515,056USD | 4,250,464USD | 32,601,553USD |
| Issuance Of Capital Stock | 2,376,181USD | 3,000,000USD | 4,011,823USD | 4,676,399USD | — |
| Change In Cash | -127,767USD | -1,654,013USD | -7,297,662USD | -11,492,268USD | 11,968,049USD |
| Begin Period Cash Flow | 220,467USD | 1,874,480USD | 9,172,142USD | 20,664,410USD | 8,696,361USD |
| End Period Cash Flow | 92,700USD | 220,467USD | 1,874,480USD | 9,172,142USD | 20,664,410USD |
| Other Cashflows From Financing Activities | -971,231USD | -528,208USD | 503,233USD | 134,913USD | 1,221,350USD |
| Unclassified Financing Cash Flow | — | — | — | — | 31,380,203USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.